Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
AssigneeAmbrx, Inc.
InventorsZhenwei Miao, Junjie Liu, Thea Norman, Russell Driver
Life of this patent
Estimating the term…
Loading patent…
AssigneeAmbrx, Inc.
InventorsZhenwei Miao, Junjie Liu, Thea Norman, Russell Driver
Estimating the term…
Disclosed herein are non-natural amino acids and polypeptides that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The non-natural amino acids, by themselves or as a part of a polypeptide, can include a wide range of possible functionalities, but typical have at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Also disclosed herein are non-natural amino acid polypeptides that are further modified post-translationally, methods for effecting such modifications, and methods for purifying such polypeptides. Typically, the modified non-natural amino acid polypeptides include at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Further disclosed are methods for using such non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, including therapeutic, diagnostic, and other biotechnology uses.
A method for treating a disorder, condition or disease, the method comprising administering a therapeutically effective amount of a non-natural amino acid polypeptide comprising at least one oxime-containing non-natural amino acid, wherein the oxime-containing non-natural amino acid is incorporated at a specific site within the polypeptide using a translation system comprising:
A method for detecting the presence of a polypeptide in a patient, the method comprising administering an effective amount of a homologous non-natural amino acid polypeptide comprising at least one oxime-containing non-natural amino acid, wherein the oxime-containing amino acid is incorporated at a specific site within the polypeptide using a translation system comprising:
A method for easing the isolation properties of a polypeptide comprising utilizing a homologous non-natural amino acid polypeptide comprising at least one oxime-containing non-natural amino acid, wherein the oxime-containing amino acid is incorporated at a specific site within the polypeptide using a translation system comprising:
Dependencies are inferred from the claim text.